Gilteritinib as Post-Transplant Maintenance for AML With Internal Tandem Duplication Mutation of <i>FLT3</i>
2024 · Journal of Clinical Oncology · 167 citations
https://doi.org/10.1200/jco.23.02474
I
Ine Moors
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
53
Papers
680
Citations
14
h-index
15
i10-index
Ine Moors is an academic researcher from Ghent University Hospital. The author has contributed to research in topics: Acute Myeloid Leukemia Research & Antifungal resistance and susceptibility & CAR-T cell therapy research. The author has an h-index of 14, co-authored 46 publications.
ORCID: 0000-0003-3079-8909Papers by this author
worksTime to look beyond one-year mortality in critically ill hematological patients?
2014 · Critical Care · 5 citations
https://doi.org/10.1186/cc13722
Coaching doctors to improve ethical decision-making in adult hospitalized patients potentially receiving excessive treatment. The CODE stepped-wedge cluster randomized controlled trial
2024 · Intensive Care Medicine · 4 citations
https://doi.org/10.1007/s00134-024-07588-0
Superiority Trials in Invasive Aspergillosis: A Harsh Reality Check With the IA-DUET (HOVON502) Trial
2024 · Clinical Infectious Diseases · 3 citations
https://doi.org/10.1093/cid/ciae501
Multicenter validation of a galactomannan chemiluminescence immunoassay for the diagnosis of pulmonary aspergillosis on serum of patients with hematological disease
2025 · Journal of Clinical Microbiology · 3 citations
https://doi.org/10.1128/jcm.01053-24
Investigating Chromosomal Radiosensitivity in Inborn Errors of Immunity: Insights from DNA Repair Disorders and Beyond
2025 · Journal of Clinical Immunology · 1 citations
https://doi.org/10.1007/s10875-025-01858-2
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat